Advertisement

Antigen/Mitogen Induced Cytolytic Activity and IL-2 Secretion in Memory-Like CTL-Hybridomas

  • Y. Kaufmann
  • M. Moscovitch
  • R. J. Robb
  • S. A. Rosenberg
  • G. Berke
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 187)

Summary

Memory-like monoclonal CTL hybridomas, derived from fusion of the AKR thymoma BW5147 with secondary CTL generated in vivo or in MLC cultures, have been used to study the mechanism whereby antigen/mitogen induces anamnestic CTL responses. Specifically, we have asked whether induction of cytolytic activity can be promoted by an antigenic/mitogenic signal without involvement of IL-2 receptors, IL-2, or other extrinsic factors. We have found that antigen/lectin alone can trigger the cytolytic potential of the hybridomas and induce IL-2 secretion. Pure IL-2 and conditioned medium were ineffective inducers of cytotoxicity. Moreover, IL-2 receptors were not detected on the hybrid cells before and after antigenic stimulation, demonstrating that expression of IL-2 receptors and induction of specific killing activity are not genetically linked. Non-activated and activated cells conjugated with target cells equally well, suggesting that induction of cytolytic activity involves a post target cell binding step. Close linkage between cytotoxicity and IL-2 secretion has been observed: induction of killing was consistently associated with IL-2 secretion and stimulation of both activities could be blocked by Cyclosporin A. IL-2 was secreted by the CTL hybrids as early as 3 h following stimulation. We propose that the immediate supply of IL-2 by such memory CTL enhances antigenic response of other, IL-2-dependent T cells.

Keywords

Conditioned Medium Hybrid Cell Cytolytic Activity Killing Assay Killing Potential 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    MacDonald, H. R. 1982. Differentiation of cytolytic T lymphocytes. Immunol. Today 3: 183.Google Scholar
  2. 2.
    Larsson, E.L., Gullberg, M., Beretta, A., and Coutinho, A. 1982. Requirement for the involvement of clonally distributed receptors in the activation of cytotoxic T lymphocytes. Immunol. Rev. 68:67.PubMedCrossRefGoogle Scholar
  3. 3.
    Nabholz, M. and MacDonald, H. R. 1983. Cytolytic T lymphocytes. Ann. Rev. Immunol. 1:273.CrossRefGoogle Scholar
  4. 4.
    Möller, G. (ed.) 1980. T cell stimulating growth factors. Immunol. Rev. 51:1–357.Google Scholar
  5. 5.
    Von Boehmer, H. and Turton, K. 1983. Autonomously proliferating K/D-restricted cytolytic T cell clones. Eur.J. Immunol. 13:176.CrossRefGoogle Scholar
  6. 6.
    Andrus, L., Granelli-Piperno, A., and Reich, E. 1984. Cytotoxic T cells both produce and respond to interleukin 2. J. Exp. Med. 59, 647.Google Scholar
  7. 7.
    Lefrancois, L., Klein, J.R., Patkau, V. and Bevan, M.J. 1984. An big en-independent activation of memory cytotoxic T cells by interleukin 2. J. Immunol. 132: 1845.PubMedGoogle Scholar
  8. 8.
    Conzelman, A., Corthesy, P., Cianfriglia, M., Silva, A., and Nabholz, M. 1982. Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity. Nature (Lond.) 298, 170.CrossRefGoogle Scholar
  9. 9.
    Widmer, M.B. and Bach, F.H. 1981. Antigen-driven helper cell-independent cloned cytolytic T lymphocytes. Nature (Lond.) 294:750.CrossRefGoogle Scholar
  10. 10.
    Kaufmann, Y., Berke, G. and Eshhar, Z. 1981. Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro. Proc. Natl. Acad. Sci. USA 78:2502.PubMedCrossRefGoogle Scholar
  11. 11.
    Kaufmann, Y. and Berke, G. 1983. Monoclonal cytotoxic T lymphocyte-hybridomas capable of specific killing activity, antigenic responsiveness and inducible interleukin (s) secretion. J. Immunol 131:50.PubMedGoogle Scholar
  12. 12.
    Walker, C.M., Rawls, W. RE., and Rosenthal, K. L. 1984. Generation of memory cell-mediated immune response after secondary infection of mice with pichinde virus. J. Immunol. 132:469.PubMedGoogle Scholar
  13. 13.
    Robb, R. J., Kutny, R.M., and Chowdhry, V. 1983. Purification and partial sequence analysis of human T cell growth factor. Proc. Natl. Acad. Sci. USA 80:5990.PubMedCrossRefGoogle Scholar
  14. 14.
    Raulet, D. H. and Bevan, M.J. 1982. A differentiation factor required for the expression of cytotoxic T cell function. Nature (Lond.) 296:754.CrossRefGoogle Scholar
  15. 15.
    Wagner, H., Hardt, C., Rouse, B.T., Rollinghoff, M., Scherich, P. and Pfizenmaier, K. 1982. Dissociation of the proliferative and differential signals controlling murine cytotoxic T lymphocyte responses. J. Exp. Med. 155: 1876.PubMedCrossRefGoogle Scholar
  16. 16.
    Finke, H. J., Scott, J., Gillis, S., and Hilfiker, M.L. 1983. Generation of alloreactive cytotoxic T lymphocytes. Evidence for a differentiation factor distinct from IL-2. J. Immunol. 130:763.PubMedGoogle Scholar
  17. 17.
    Robb, R.J., Munck, A. and Snith, K.A. 1981. T cell growth factor receptors. Quantitation, specificity and biological relevance. J. Exp. Med. 165: 1455.CrossRefGoogle Scholar
  18. 18.
    Robb, R.J. and Lin, Y. 1983. T cell growth factor: purification, interaction with the cellular receptor and in vitro synthesis. In: Thymic Hormones and Lymphokines, Goldstein, A.L., ed., Plenum Press, New York, in press.Google Scholar
  19. 19.
    Conzelman, A., Silva, A., Cianfriglia, M., Tougne, C., Sekaly, R. P. and Nabholz, M. 1982. Correlated expression of TCGF dependence, sensitivity to Vicia villosa lectin, and cytolytic activity in hybrids between cytolytic T cells and T lymphomas. J. Exp. Med. 156: 1335.CrossRefGoogle Scholar
  20. 20.
    Davignon, D., Martz, E., Reynolds, T., Kurzinger, K. and Springer, T.A. 1981. Lymphocyte function-associated antigen one (LFA-1): A surface antigen distinct from Lyt-2/3 that participates in T lymphocyte-mediated killing. Proc. Natl. Acad. Sci. USA 78:4535.PubMedCrossRefGoogle Scholar
  21. 21.
    Pierres, M., Goridis, C. and Golstein, P. 1982. Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94,000 and 180,000 molecular weight. Eur. J. Immunol. 12:60.PubMedCrossRefGoogle Scholar
  22. 22.
    Bunjes, D., Hardt, C., Rollinghoff, H. and Wagner, H. 1981. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of Interleukin 1 and Interleukin 2. Eur. J. Immunol. 11:657.PubMedCrossRefGoogle Scholar
  23. 23.
    Palacios, R. 1981. Cyclosporin A inhibits the proliferative response and the generation of helper, suppressor and cytotoxic T cell functions in the autologous mixed lymphocyte reaction. Cell. Immunol. 61:453.PubMedCrossRefGoogle Scholar
  24. 24.
    Orosz, C.C., Fidelus, R.K., Roopenian, D.C., Widmer, M.B., Ferguson, R.M. and Bach, F.H. 1982. Analysis of cloned T cell function, I. Dissection of cloned T cell proliferative responses using Cyclosporin A. J.. Immunol. 129: 1865.PubMedGoogle Scholar
  25. 25.
    Wang, B., Heacock, E., Collins, K., Hutchinson, I., Tilney, N. and Mannick, J. 1981. Suppressive effects of Cyclosporin A on the induction of alloreactivity in vitro and in vivo. J. Immunol. 127:89.PubMedGoogle Scholar
  26. 26.
    Kaufmann, Y., Golstein, P., Pierres, M., Springer, T.A. and Eshhar, Z. 1982. LFA-1 but not Lyt-2 is associated with killing activity of cytotoxic T lymphocyte hybridomas. Nature (Lond.) 300:357.CrossRefGoogle Scholar
  27. 27.
    Berke, G., Gabison, D. and Feldman, M. 1975. The frequency of effector cells in populations containing cytotoxic T lymphocytes. Eur. J. Immunol. 5:813.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Y. Kaufmann
    • 1
  • M. Moscovitch
    • 1
  • R. J. Robb
    • 2
  • S. A. Rosenberg
    • 3
  • G. Berke
    • 1
  1. 1.Department of Cell BiologyThe Weizmann Institute of ScienceRehovotIsrael
  2. 2.Glenolden LaboratoryE. I. duPont deNemours and Co.GlenoldenUSA
  3. 3.Surgery BranchNational Cancer InstituteBethesdaUSA

Personalised recommendations